Related Experiment Videos
Establishment of a human fetal cardiac myocyte cell line
Y C Wang1, N Neckelmann, A Mayne
1Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322.
Insights
Researchers developed a new human cardiac cell line (W1) from fetal myocytes. This cell line offers a stable model for studying cardiac diseases and drug effects, overcoming limitations of primary cell cultures.
Area of Science:
- Cardiology
- Cell Biology
- Biomedical Research
Background:
- Human cardiac myocytes are crucial for heart function but difficult to study in vitro due to degeneration in disease states.
- Current limitations in culturing adult human cardiac myocytes hinder research into cardiac diseases and drug toxicity.
- Fetal cardiac myocytes are easier to culture but present challenges like limited availability and cell type variability.
Purpose of the Study:
- To establish a continuous, well-characterized cell line of human cardiac origin for research purposes.
- To overcome the limitations associated with primary human cardiac myocyte cultures.
- To provide a reliable model for investigating the effects of cardiotropic viruses and cardiotoxic drugs.
Main Methods:
- Derivation of a cell line (W1) from highly enriched human fetal cardiac myocytes.
- Transfection of myocytes with plasmids pSV2Neo and pRSVTAg.
- Morphologic and phenotypic characterization using flow microfluorometry and immunoperoxidase techniques.
Main Results:
- A stable human cardiac cell line (W1) was established and maintained in culture for over 1 year.
- W1 cells exhibited properties consistent with human fetal cardiac myocytes.
- W1 cells showed no reactivity to antibodies specific for endothelial, epithelial, skeletal muscle, or dendritic cells, indicating purity.
Conclusions:
- The W1 cell line represents a promising, established model system for studying human cardiac myocytes.
- This cell line may facilitate research into mechanisms of cardiac myocyte degeneration in various diseases.
- W1 cells offer a valuable tool for evaluating the cardiotoxic effects of drugs and viruses in a controlled in vitro setting.
Abstract:
Human cardiac myocytes undergo degeneration, cytolysis, and necrosis in a number of clinical disease conditions such as myocarditis, dilated cardiomyopathy, and during episodes of cardiac allograft rejection. The precise cellular, biochemical, and molecular mechanisms that lead to such abnormalities in myocytes have been difficult to investigate because at present it is not possible to obtain and maintain viable cell cultures of human adult cardiac myocytes in vitro. However, human fetal cardiac myocytes are relatively easy to maintain and culture in vitro, but their limited availability and growth, variability from one preparation to another, and varying degrees of contamination with endothelial and epithelial cell types have made it difficult to obtain reliable data on the effect of cardiotropic viruses and cardiotoxic drugs on such myocytes. These thoughts prompted us to attempt to derive a cell line of human cardiac origin. Highly enriched human fetal cardiac myocytes were transfected with the plasmids pSV2Neo and pRSVTAg and gave rise to a cell line (W1) which has been maintained in culture for 1 yr. Morphologic and phenotypic analyses of W1 cells by flow microfluorometry and immunoperoxidase techniques indicate that the W1 cell line shares many properties of human fetal cardiac myocytes, but appears not to react with specific antibodies known to react with markers unique to human endothelial, epithelial, skeletal muscle, and dendritic cells. These preliminary data suggest that the W1 cells may provide a unique source of an established cell line that shares many properties ascribed to human cardiac myocytes.